Objective To explore the effects of somatostatin on the levels of gastrointestinal hormones and clinical outcomes in critically ill infants after gastrointestinal surgery. Methods Using a random number table method, critically ill infants after gastrointestinal surgery who were admitted to the Intensive Care Unit of Xuzhou Children's Hospital from June 2019 to June 2021 were randomly divided into an observation group (29 cases) and a control group (30 cases). The control group received routine treatment such as anti-infection and hemostasis after surgery, while the observation group received somatostatin in addition to the routine treatment [3.5 μg/(kg·h) infusion for 7 days]. The levels of serum gastrin (GAS), motilin (MTL), insulin, and glucagon-like peptide-1 (GLP-1) before surgery, on the 3rd day after surgery, and on the 7th day after surgery were compared between the two groups. The recovery progress and incidence of complications after surgery were also compared between the two groups. Results There was no significant difference in the levels of serum GAS, MTL, insulin, and GLP-1 between the two groups before surgery (P>0.05). On the 3rd and 7th day after surgery, the levels of serum GAS, MTL, insulin, and GLP-1 in the observation group were higher than those in the control group (P<0.05). In the observation group, the levels of GAS, MTL, insulin, and GLP-1 on the 7th day after surgery were higher than those before surgery and on the 3rd day after surgery (P<0.05), and the levels on the 3rd day after surgery were higher than those before surgery (P<0.05). There was no significant difference in the levels of serum GAS, MTL, and insulin before surgery, on the 3rd day after surgery, and on the 7th day after surgery in the control group (P>0.05). The level of GLP-1 on the 7th day after surgery was higher than that before surgery and on the 3rd day after surgery (P<0.05), and the level on the 3rd day after surgery was higher than that before surgery (P<0.05) in the control group. The observation group had shorter first time of anal exhaust, recovery time of bowel sounds, and first time of defecation after surgery compared to the control group (P<0.05). The incidence of complications after surgery in the observation group was lower than that in the control group (10% vs 33%, P<0.05). Conclusions Somatostatin can increase the levels of serum GAS, MTL, insulin, and GLP-1 in critically ill infants after gastrointestinal surgery, promote the recovery of gastrointestinal function, and reduce the incidence of postoperative complications.
Key words
Somatostatin /
Gastrointestinal hormone /
Critical illness /
Gastrointestinal surgery /
Infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 Li WJ, Gao C, An LX, et al. Perioperative transcutaneous electrical acupoint stimulation for improving postoperative gastrointestinal function: a randomized controlled trial[J]. J Integr Med, 2021, 19(3): 211-218. PMID: 33495134. DOI: 10.1016/j.joim.2021.01.005.
2 雷婷, 李茜, 刘萍. 生长抑素、奥曲肽和垂体后叶素治疗食管静脉曲张破裂出血患者系统性和肝脏血流动力学的变化比较[J]. 实用肝脏病杂志, 2018, 21(6): 911-915. DOI: 10.3969/j.issn.1672-5069.2018.06.021.
3 郑传明, 王振杰, 蔡腾, 等. 生长抑素联合丙氨酰谷氨酰胺在急性粘连性肠梗阻中的应用效果[J]. 南昌大学学报（医学版）, 2017, 57(1): 43-45. DOI: 10.13764/j.cnki.ncdm.2017.01.011.
4 祁伯祥, 朱磊, 盛利平, 等. 生长抑素对急腹症患儿术后胃肠功能及应激水平影响的前瞻性随机对照研究[J]. 中国当代儿科杂志, 2022, 24(7): 812-816. PMID: 35894198. PMCID: PMC9336631. DOI: 10.7499/j.issn.1008-8830.2203098.
5 商磊. 生长抑素（施他宁）预防新生儿肠吻合术后消化道出血疗效观察[J]. 中医临床研究, 2013, 5(23): 96-97. DOI: 10.3969/j.issn.1674-7860.2013.23.058.
6 祁伯祥, 朱磊, 商磊, 等. 生长抑素治疗新生儿术后消化道出血的疗效及安全性研究[J]. 中国当代儿科杂志, 2016, 18(11): 1065-1068. PMID: 27817766. PMCID: PMC7389866. DOI: 10.7499/j.issn.1008-8830.2016.11.002.
7 《中国国家处方集》编委会. 中国国家处方集: 化学药品与生物制品卷（儿童版）[M]. 北京: 人民军医出版社, 2013: 166.
8 Mohammed AR, Eid AR, Elzehery R, et al. Effect of oropharyngeal administration of mother's milk prior to gavage feeding on gastrin, motilin, secretin, and cholecystokinin hormones in preterm infants: a pilot crossover study[J]. JPEN J Parenter Enteral Nutr, 2021, 45(4): 777-783. PMID: 32458450. DOI: 10.1002/jpen.1935.
9 Rai U, Thrimawithana TR, Valery C, et al. Therapeutic uses of somatostatin and its analogues: current view and potential applications[J]. Pharmacol Ther, 2015, 152: 98-110. PMID: 25956467. DOI: 10.1016/j.pharmthera.2015.05.007.
10 Ren X, Wang Y, He Z, et al. Effects of cefuroxime axetil combined with Xingpi Yanger granules on the serum gastrin, motilin, and somatostatin levels in children with upper respiratory tract infection accompanied by diarrhea: results of a randomized trial[J]. Transl Pediatr, 2021, 10(8): 2106-2113. PMID: 34584881. PMCID: PMC8429862. DOI: 10.21037/tp-21-314.
11 O'Malley D. Endocrine regulation of gut function: a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome[J]. Exp Physiol, 2019, 104(1): 3-10. PMID: 30444291. DOI: 10.1113/EP087443.
12 邹敏, 刘文, 李荣, 等. 腹腔镜手术对重症急性胰腺炎患者胃肠功能及应激指标的影响[J]. 中国临床医生杂志, 2019, 47(3): 313-316. DOI: 10.3969/j.issn.2095-8552.2019.03.021.
13 Seyyedmajidi M, Ahmadi A, Hajiebrahimi S, et al. Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication[J]. J Res Pharm Pract, 2016, 5(4): 248-251. PMID: 27843960. PMCID: PMC5084481. DOI: 10.4103/2279-042X.192462.
14 Sun L, Coy DH. Somatostatin and its analogs[J]. Curr Drug Targets, 2016, 17(5): 529-537. PMID: 26951062. DOI: 10.2174/1389450116666141205163548.
15 Paternoster S, Falasca M. Dissecting the physiology and pathophysiology of glucagon-like peptide-1[J]. Front Endocrinol (Lausanne), 2018, 9: 584. PMID: 30364192. PMCID: PMC6193070. DOI: 10.3389/fendo.2018.00584.
16 Stano S, Alam F, Wu L, et al. Effect of meal size and texture on gastric pouch emptying and glucagon-like peptide 1 after gastric bypass surgery[J]. Surg Obes Relat Dis, 2017, 13(12): 1975-1983. PMID: 29055668. PMCID: PMC5759771. DOI: 10.1016/j.soard.2017.09.004.
17 王剑锋, 刘国庆, 唐华健, 等. 生长抑素在小儿重症急腹症术后的应用[J]. 广东医学, 2015, 36(2): 299-300. DOI: 10.13820/j.cnki.gdyx.2015.02.074.
18 Hernández C, Arroba AI, Bogdanov P, et al. Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes[J]. J Clin Med, 2020, 9(8): 2579. PMID: 32784955. PMCID: PMC7463891. DOI: 10.3390/jcm9082579.
19 丁平, 王选举. 生长抑素与乌司他丁联合肠内营养治疗重症急性胰腺炎患者的临床研究[J]. 中国临床药理学杂志, 2020, 36(1): 10-13. DOI: 10.13699/j.cnki.1001-6821.2020.01.003.
PDF(571 KB)
